Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | HTR2B | P41595 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.35 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8674907 | 0.94 | LMNA (0.42) | LMNACA1CA2TRPA1CHRM1 | |
| SCHEMBL9064530 | 0.88 | LMNA (0.39) | LMNACA1CA2TRPA1CHRM1 | |
| SCHEMBL8674666 | 0.87 | LMNA (0.42) | LMNACA1CA2TRPA1CHRM1 | |
| SCHEMBL10436723 | 0.81 | CYP3A4 (0.36) | LMNACYP3A4TSHRMAPK1 | |
| SCHEMBL23625218 | 0.78 | LMNA (0.34) | LMNACA1CA2TRPA1CHRM1 | |
| SCHEMBL12297358 | 0.78 | LMNA (0.59) | LMNACA1CA2TRPA1CHRM1 | |
| SCHEMBL14924905 | 0.78 | LMNA (0.41) | LMNACA1CA2TRPA1CHRM1 | |
| SCHEMBL1487434 | 0.78 | LMNA (0.59) | LMNACA1CA2TRPA1CHRM1 | |
| SCHEMBL13588022 | 0.78 | GABRA1 (0.34) | LMNACA1CA2TRPA1CHRM1 | |
| SCHEMBL23430759 | 0.78 | EIF4A3 (0.37) | LMNACA1CA2TRPA1CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1115321-C | Production method of pyromellitic acid | PETROCHEMISTRY INST HEILONGJIA (CN) | 2003-07-23 | — | — | CN | claimed |
| CN-1245793-A | Production method of pyromellitic acid | BRANCH OF PETROCHEMISTRY INST (CN) | 2000-03-01 | — | — | CN | claimed |
| CN-1245171-A | Process for preparing sym-phenyltetraformic dianhydride | INST OF PETRO CHEMISTRY HEILON (CN) | 2000-02-23 | — | — | CN | claimed |
| US-3992418-A | Production of pyromellitic dianhydride | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-11-16 | — | — | US | claimed |
| CN-115253988-A | Pyromellitic acid continuous anhydride forming device | 江苏正丹化学工业股份有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-111960939-B | Preparation method for preparing pyromellitic acid based on catalytic oxidation-hydrolysis-fractional crystallization | 连云港鹏辰特种新材料有限公司 | 2021-12-28 | — | — | CN | disclosed |
| CN-111960939-A | Preparation method for preparing pyromellitic acid based on catalytic oxidation-hydrolysis-fractional crystallization | 连云港鹏辰特种新材料有限公司 | 2020-11-20 | — | — | CN | disclosed |
| US-20170044112-A1 | HYDROPHOBICALLY TAGGED JANUS KINASE INHIBITORS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2017-02-16 | — | — | US | disclosed |
| CN-102153457-B | Method for preparing 2,3,5-trimethyl hydroquinone intermediate (2,3,5-trimethyl benzoquinone) by unsym-trimethyl benzene oxidation | NANTONG BAISHENG CHEMICAL CO LTD | 2013-03-06 | — | — | CN | disclosed |
| CN-102659522-A | Simple preparation method of 2,3,5-trimethylhydroquinone and method for preventing 2,3,5-trimethylhydroquinone from being oxidized in production or storage process | UNIV SHANDONG | 2012-09-12 | — | — | CN | disclosed |
| CN-102153457-A | Method for preparing 2,3,5-trimethyl hydroquinone intermediate (2,3,5-trimethyl benzoquinone) by unsym-trimethyl benzene oxidation | NANTONG BAISHENG CHEMICAL CO LTD | 2011-08-17 | — | — | CN | disclosed |
| CN-101033174-B | Method for preparing 2,3,5-trimethylphenol | ANHUI KELIAN IND CO LTD | 2010-11-24 | — | — | CN | disclosed |
| CN-1245171-A | Process for preparing sym-phenyltetraformic dianhydride | INST OF PETRO CHEMISTRY HEILON (CN) | 2000-02-23 | — | — | CN | disclosed |
| CN-1136041-A | Rifinement of pyromellitic acid dianhydride by hot air carrying process | WEN DIANWU (CN) | 1996-11-20 | — | — | CN | disclosed |
| EP-0629680-A1 | Process for separating high purity durene | UOP (US) | 1994-12-21 | — | — | EP | disclosed |
| US-5223589-A | Lithium-exchaged X zeolite as adsorbent | UOP (US) | 1993-06-29 | — | — | US | disclosed |
| US-4219570-A | Insect repellents and a method of repelling insects | AJINOMOTO COMPANY, INCORPORATED (JP) | 1980-08-26 | — | — | US | disclosed |
| US-4014755-A | Method of refining pyromellitic acid dianhydride | VEBA-CHEMIE AG (DT) | 1977-03-29 | — | — | US | disclosed |
| US-3992418-A | Production of pyromellitic dianhydride | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
| US-3992418-A | Production of pyromellitic dianhydride | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044112-A1 | HYDROPHOBICALLY TAGGED JANUS KINASE INHIBITORS AND USES THEREOF | JAK1, JAK3, JAK2 | LMNA 4834/4885CA1 4198/4885CA2 3363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.